Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLymphoma
Indication DetailsTreat lymphoma; Treat recurrent lymphoid malignancies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today